Accelrys Buys VelQuest for $35M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelrys today announced the $35 million all-cash acquisition of VelQuest in a deal that extends the San Diego-based company's capabilities beyond research into the quality assurance and quality control phases of product development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.